Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes

BACKGROUND: Immunotherapy has shown promising efficacy in patients with nasopharyngeal carcinoma (NPC). Lymphocyte activating 3 gene (LAG-3) represents a significant immune target, however, its relationship with NPC remains unclear. This study aimed to evaluate LAG-3 expression in NPC and its associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Fan, Cao, Jiaxin, Lu, Feiteng, Zeng, Kangmei, Ma, Wenjuan, Huang, Yan, Zhang, Li, Zhao, Hongyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403354/
https://www.ncbi.nlm.nih.gov/pubmed/34454491
http://dx.doi.org/10.1186/s12935-021-02162-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403354/
https://www.ncbi.nlm.nih.gov/pubmed/34454491
http://dx.doi.org/10.1186/s12935-021-02162-w

Ejemplares similares